Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)-Reference-Cited by-同舟云学术

Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Published:2008-02 Issue:2 Volume:108 Page:298-305
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Goldberg Hadassah,Miller Robert C.,Abdah-Bortnyak Roxolyana,Steiner Mariana,Yıldız Ferah,Meirovitz Amichay,Villà Salvador,Poortmans Philip M.P.,Azria David,Zidan Jamal,Ozsahin Mahmut,Abacioglu Ufuk,Gold Douglas G.,Amit Amnon,Lavie Ofer,Atahan I. Lale,Kuten Abraham

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference25 articles.

1. Endometrial cancer: the management of high-risk disease;Kristensen;Curr Oncol Rep,2004

2. Uterine serious carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features;Sherman;M J Surg Pathol,1992

3. A review of the pathology and management of uterine papillary serious carcinoma and correlation with outcome;Faratian;Int J Gynecol Cancer,2006

4. Diagnostic Gynecologic and Obstetric Pathology,2006

5. Improved survival in surgical stage I patients with uterine papillary serious carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy;Kelly;Gynecol Oncol,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma;Scientific Reports;2024-03-11

2. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study;Journal of Obstetrics and Gynaecology;2022-12-12

3. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center;European Journal of Surgical Oncology;2022-01

4. Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer;Advances in Radiation Oncology;2020-11

5. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial;The Lancet Oncology;2019-09